Home > Boards > US OTC > Biotechs >

CytRx Corp. (CYTR)

CYTR RSS Feed 		Add CYTR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/26/2022 10:01:47 AM - Followers: 212 - Board type: Free - Posts Today: 0

BRUTALLY underpriced Biotech with a laughable market cap of only $10 million trading under their Cash balance of $18.5 million (or Cash untill 2023+)  . CYTR has a very large pipeline with multiple Phase 3 und Phase 2 partnered programs ongoing targeting Rare Diseases and Cancer .Most advanced Drug is Arimoclomol for the treatment of Nieman-Pick Disease for which they expect to submit NDA and MAA in Q2 with potential approval in the US and Europe in Q4 this will trigger a $10 million milestone payment to CYTR . More Big News expected within 6 months like the Phase 2 readout of the Gaucher Disease trial and the Phase 3 interim results of sIBM trial (more infos below)  .This low float stock has everything to be the next 10+ Bagger at current price the stock is more than a PURE GIFT . STRONG BUY and GL


CytRx (CYTR)

Market-Cap: $9,8 M
Cash: $18,5 M ( Cash untill 2023+ )
Price: $0,29

Shares Out: 33,6 M

Burn-rate: only $1.2 M per Quarter
NO Debt


Upcoming Catalysts of the Rare Disease Pipeline :

Niemann-Pick disease Type C (NPC)--Early access program in January -- NDA/MAA filing in Q2 2020 ---There are no approved treatments for NPC in the USA and only one approved product in Europe. Arimoclomol has been granted Orphan Drug Designation (EU and USA), Rare Pediatric Disease Designation (USA), and Fast Track designation (USA) for the treatment of NPC.

Sporadic Inclusion Body Myositis (sIBM) Phase 2/3 interim results in Q1 2020 -- very large market potential --There are no approved treatments for sIBM. Arimoclomol has been granted Orphan Drug Designation (EU and USA) for the treatment of sIBM. 

Amyotrophic Lateral Sclerosis (ALS) interim results Q1/Q2 2020 --very large market potential --Currently, there are only limited treatment options available. Arimoclomol has been granted Orphan Drug Designation (EU and USA) for the treatment of ALS.

Gaucher disease typ III--Phase 2 results in Q1 ---Effective treatments are available for the systemic manifestations of the disease – however, no therapies are available for the neurological symptoms.



Presentation December 2019
http://www.cytrx.com/wp-content/uploads/2019/12/CYTR-Corp-Overview-December-2019-Non-Conf.pdf


CytRx Corporation - Biopharmaceutical Company Discusses Near Term Value from Out-License Deals and Growth Drivers
https://stocknewsnow.com/commentary/ANEWSID26062019100002/VIDEO-CytRx-Corporation-(OTCQB-CYTR)


Orphazyme’s arimoclomol receives US Fast Track designation in sporadic Inclusion Body Myositis
https://finance.yahoo.com/news/orphazyme-arimoclomol-receives-us-fast-060058985.html


Orphazyme receives Breakthrough Therapy Designation for arimoclomol in Niemann-Pick Disease Type C (NPC)
https://finance.yahoo.com/news/orphazyme-receives-breakthrough-therapy-designation-060000973.html








CYTR
Current Price
Volume:
Bid Ask Day's Range
CYTR Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CYTR News: Current Report Filing (8-k) 05/19/2022 01:31:15 PM
CYTR News: Securities Registration (section 12(g)) (8-a12g) 05/19/2022 01:04:11 PM
CYTR News: Quarterly Report (10-q) 05/12/2022 02:17:22 AM
CYTR News: Notice of Effectiveness (effect) 03/28/2022 02:05:15 AM
CYTR News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 03/25/2022 12:20:21 PM
PostSubject
#7743   Wth happened!! 15 cents?? Jagz16 04/26/22 10:01:47 AM
#7742   Volume selling today.. willlbone 04/19/22 01:14:12 PM
#7741   Do we think Kriegsman also snowed Snowdy? learningcurve2020 04/19/22 09:35:32 AM
#7740   It was always a Scam SpaceTimeRift777 04/16/22 05:18:42 PM
#7739   Starting to truly believe it’s a scam!! I’ve Jagz16 04/13/22 12:50:50 PM
#7738   IS THIS STOCK A SCAM OR WHAT??? Banjo50 03/01/22 03:50:32 AM
#7737   Bravo!!! So long Kriegsman! CytRx Corporation (OTCQB:CYTR) ("CytRx" learningcurve2020 01/04/22 01:40:53 PM
#7736   Dilute, dilute, dilute. Kreigsman needs his salary and wrk_SATX 07/13/21 11:33:00 AM
#7735   CYTR...97...https://www.otcmarkets.com/stock/CYTR/news/CytRx-Comments-on-Orphazy georgie18 06/30/21 09:12:56 AM
#7734   CYTR...92...Bullish Descent Block Reversal Pattern to the Upside...Open georgie18 06/24/21 07:06:10 AM
#7733   And, all we get is a vague PR learningcurve2020 06/23/21 08:55:28 AM
#7732   LOL...This never showed a profit, cash incinerator, CYTR n4807g 06/23/21 06:47:32 AM
#7731   Kreigsman Special. learningcurve2020 06/22/21 10:00:29 AM
#7730   FDA doesn't like their arimoclomol for Nose-Pick disease. willlbone 06/21/21 03:07:56 PM
#7729   CYTR...Filled some at .88...:party: georgie18 06/21/21 10:18:00 AM
#7728   CYTR...$1.08...Back in on the dip and looking for georgie18 06/19/21 06:24:44 AM
#7727   It'll be busy today.... n4807g 06/18/21 05:48:58 AM
#7726   Oops..... n4807g 06/18/21 05:47:27 AM
#7725   Those royalties about to be kickin in nicely OTC_Buyer 06/14/21 11:38:10 PM
#7724   in aristotelisonassis 06/10/21 03:07:27 PM
#7723   And what’s that?? blackpilled 06/10/21 02:19:45 PM
#7722   What's happening?!?!? Whatever it is I like it! coffee880 06/10/21 02:19:42 PM
#7721   so quiet here considering whats about to happen! juas 06/10/21 01:55:45 PM
#7720   CYTR...$1.52...Bullish Harami forming on the daily...:partying_face: georgie18 06/07/21 10:05:50 AM
#7719   CYTR...$1.81...:party: [9:41 AM] georgie18 05/24/21 09:42:36 AM
#7718   Might buy some in the 80s today. willlbone 05/12/21 10:26:01 AM
#7717   Revenues, 32 MILLION shares, and Audited financials give jacksira 05/11/21 04:31:34 PM
#7716   That's a logical guess. The chart says some slow_feet 01/14/21 01:36:31 PM
#7715   I have always thought they end up in NK eom7 01/14/21 01:19:11 PM
#7714   Yeah, I think that last 8-K says we're slow_feet 01/14/21 11:50:03 AM
#7713   lol. They wont let me back in... eom7 01/14/21 11:37:02 AM
#7712   Morning, Good trade! slow_feet 01/14/21 08:09:41 AM
#7711   Sold on shake... now I need to chase. eom7 01/14/21 01:28:05 AM
#7710   Actually the word "parachute" is too harsh, more slow_feet 01/08/21 06:19:43 PM
#7709   :) slow_feet 01/08/21 04:24:35 PM
#7708   Got ya, It all became a little clearer, john sezso 01/08/21 04:20:31 PM
#7707   It wasn't a criticism, merely a precursor for slow_feet 01/08/21 07:53:01 AM
#7706   I say tomato and some say potato, john sezso 01/08/21 07:50:33 AM
#7705   Yes, and: slow_feet 01/08/21 07:32:00 AM
#7704   Mr. Caloz has entered into a new employment john sezso 01/08/21 07:27:54 AM
#7703   https://ih.advfn.com/stock-market/USOTC/cytrx-qb-CYTR/stock-news/84052659/c slow_feet 01/08/21 06:16:45 AM
#7702   For the newly curious about CYTR: john sezso 01/01/21 08:55:56 PM
#7701   Bouncing back quickly... slow_feet 12/29/20 10:53:20 AM
#7700   Spoke too soon. eom7 12/29/20 10:49:33 AM
#7699   Enjoy... georgie18 12/29/20 10:18:03 AM
#7698   TY! lol eom7 12/29/20 10:16:03 AM
#7697   Fantastic...call...lol... georgie18 12/29/20 10:10:16 AM
#7696   Very quiet...and still an MC under 100M. slow_feet 12/29/20 09:53:22 AM
#7695   $2 wall is up... board is quit for eom7 12/29/20 09:50:58 AM
#7694   $2 eom7 12/29/20 09:50:09 AM
PostSubject
© 2022 InvestorsHub.com, Inc.
Consent Preferences